Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
Abstract Developing therapeutics that target multiple receptor signaling pathways in tumors is critical as therapies targeting single specific biomarker/pathway have shown limited efficacy in patients with cancer. In this study, we extensively characterized a bi-functional molecule comprising of epi...
Main Authors: | Yanni Zhu, Nicole Bassoff, Clemens Reinshagen, Deepak Bhere, Michal O. Nowicki, Sean E. Lawler, Jérémie Roux, Khalid Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-02483-9 |
Similar Items
-
Stochastic models of lymphocyte proliferation and death.
by: Anton Zilman, et al.
Published: (2010-09-01) -
Cell proliferation, cell death, and differentiation in gliomas
by: Ellison, David William
Published: (1995) -
Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
by: Colleen M. Britain, et al.
Published: (2018-02-01) -
Zearalenone Promotes Cell Proliferation or Causes Cell Death?
by: Wanglong Zheng, et al.
Published: (2018-05-01) -
Analysis of the molecular regulation of cell proliferation and cell death
by: Harrington, Elizabeth Anne
Published: (1995)